Cytek Biosciences, Inc. (CTKB) Reports Break-Even Earnings for Q1Zacks Investment Research • 05/09/23
Cytek Biosciences, Inc. (CTKB) Soars 13.4%: Is Further Upside Left in the Stock?Zacks Investment Research • 04/27/23
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023GlobeNewsWire • 04/20/23
Here's Why Cytek Biosciences, Inc. (CTKB) is Poised for a Turnaround After Losing -16.6% in 4 WeeksZacks Investment Research • 03/29/23
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 02/28/23
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences CompletedGlobeNewsWire • 02/28/23
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinGlobeNewsWire • 02/13/23
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023GlobeNewsWire • 02/07/23
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More - Corcept Therapeutics (NASDAQ:CORT), Cytek Biosciences (NASDAQ:CTKB)Benzinga • 12/15/22
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022GlobeNewsWire • 10/26/22
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 08/30/22
Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2022 Results Earnings Call TranscriptSeeking Alpha • 08/11/22